AZN vs RVTY · P/E 28, $288.38B cap vs P/E 42, rev $1.44B
AstraZeneca PLC (AZN) versus Revvity Inc. (RVTY) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Revvity Inc. (RVTY) is a diagnostics & research company listed on US.
AZN does not have a complete income-statement cache yet.
Latest reported RVTY revenue for 2026-07-05 was $1.44B. Net income was $92.5M. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. RVTY currently screens at market cap $11.94B and trailing P/E 41.9.
Not investment advice. Open the AZN and RVTY stock pages for the full models.
Not investment advice.